MOESM1 of Complement lectin pathway protein levels reflect disease activity in juvenile idiopathic arthritis: a longitudinal study of the Nordic JIA cohort
Mia Glerup
Steffen Thiel
Veronika Rypdal
Ellen Arnstad
Maria Ekelund
Suvi Peltoniemi
Kristiina Aalto
Marite Rygg
Susan Nielsen
Anders Fasth
Lillemor Berntson
Ellen Nordal
Troels Herlin
10.6084/m9.figshare.9790373.v1
https://springernature.figshare.com/articles/journal_contribution/MOESM1_of_Complement_lectin_pathway_protein_levels_reflect_disease_activity_in_juvenile_idiopathic_arthritis_a_longitudinal_study_of_the_Nordic_JIA_cohort/9790373
Additional file 1: Table S1. Clinical characteristics of participants in the Nordic JIA cohort at baseline. y* = mean in years ±SD,** = active joint count at the visit 6 months after onset (− 1/+ 2 months), *** = cumulative joint count during the first 6 months (− 1/+ 2 months) after disease onset, ****DMARDs = Disease modifying anti-rheumatic drugs at the baseline visit, ANA = antinuclear antibodies, HLA-B27 = human leucocyte antigen B27, CRP = C-Reactive Protein, ESR = Erythrocyte Sedimentation Rate, IQR = 1st-3rd interquartile range, JADAS71 = juvenile arthritis disease activity score of 71 joints, sJIA = systemic JIA, Oligo persist = oligo persistent JIA, Oligo ext. = oligo extended JIA, Poly RF- = polyarticular rheumatoid factor negative JIA, Poly RF+ = polyarticular rheumatoid factor positive JIA, ERA = enthesitis-related arthritis, Undiff = undifferentiated JIA. (DOCX 17 kb)
2019-09-10 04:57:17
JIA
Lectin pathway proteins
Disease activity